Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has the Drug Eluting Stent Market Growth Performance Trended Historically, And What Lies Ahead?

In recent times, the market size of drug eluting stent has seen a robust increase. The market is projected to inflate from $7.63 billion in 2024 to $8.29 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 8.6%. Factors contributing to this growth during the historic period include the demand for better treatment alternatives, clinical proof, regulatory consent, healthcare finance, and guidelines and suggestions.

What Is the Forecast for the Drug Eluting Stent Market Size Through 2029?

In the coming years, the market size for drug eluting stents is set for a significant expansion. It’s projected to escalate to $11.37 billion by 2029, indicating a compound annual growth rate (CAGR) of 8.2%. Factors contributing to this growth during the forecast period include an older population dealing with chronic diseases, broader applications for the stents, healthcare reimbursement plans, and a worldwide expansion of the market alongside a focus on patient-centered care. The forecast period is also expected to witness key trends such as personalized treatment, less invasive procedures, developments in healthcare technology, and advanced drug formulations.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15557&type=smp

What are the Key Market Players in Drug Eluting Stent Market and How They’re Evolving?

Major companies operating in the drug eluting stent market are Johnson & Johnson Services Inc., Abbott, Medtronic plc, Boston Scientific Corporation, Terumo Corporation, InspireMD Inc., B. Braun Melsungen AG, Cook Group Incorporated, Lepu Medical Technology (Beijing) Co. Ltd., Biotronik, Meril Life Sciences Pvt. Ltd., MicroPort Scientific Corporation, Biosensors International Group Ltd., OrbusNeich Medical Company Limited, Alvimedica Medical Technologies, Hexacath, Elixir Medical Corporation, Translumina GmbH, Cardionovum GmbH, QualiMed Innovative Medizinprodukte GmbH, InSitu Technologies Inc., Acrostak AG, SINOMED Innovation Inc., Svelte Medical Systems Inc.

What Are the Primary Growth Drivers in the Drug Eluting Stent Market?

The drug-eluting stent market is projected to grow due to the increasing prevalence of coronary heart disease. This health condition, characterized by narrowing or blockage of the coronary arteries due to plaque accumulation, can potentially result in grave outcomes like heart attacks or chest pain. Sedentary lifestyles, poor dietary habits, aging demographics, and increased awareness are contributing to a rise in cases of coronary heart disease. Drug-eluting stents (DES), being effective in widening narrowed or blocked coronary arteries and dispensing medicine to avert re-narrowing (restenosis) of the artery, are found to be beneficial for this disease. As per the Centers for Disease Control and Prevention, a government agency based in the U.S., in May 2024, coronary heart disease’s prevalence in adults aged 18 and above had risen from 4.6% in 2020 to 4.9% in 2022. This accelerating rate of coronary heart disease is anticipated to boost the drug-eluting stent market’s growth.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=15557&type=smp

What Are the Leading Segments in the Global Drug Eluting Stent Industry?

The drug eluting stent market covered in this report is segmented –

1) By Product: Polymer-Based, Polymer-Free

2) By Drug: Sirolimus, Paclitaxel, Zotarolimus, Everolimus, Biolimus, Other Drugs

3) By Scaffold: Cobalt-Chromium, Platinum-Chromium, Nitinol, Biodegradable, Other Scaffolds

4) By Application: Coronary Diseases, Peripheral Vascular Diseases

5) By End-User: Hospitals, Specialty Clinic

Subsegments:

1) By Polymer-Based: Durable Polymer Drug-Eluting Stents, Biodegradable Polymer Drug-Eluting Stents

2) By Polymer-Free: Bare-Metal Stents With Drug Coating, Other Polymer-Free Drug-Eluting Stents

What Are the Key Market Trends in the Drug Eluting Stent Industry?

Companies in the drug-eluting stent market are concentrating on the creation of groundbreaking delivery systems, like the dual-layer balloon, with the aim of enhancing patient results and elevating the practice of interventional cardiology. A dual-layer balloon within a drug-eluting stent system brings about increased accuracy in drug distribution and stent deployment by ensuring superior management and balanced drug exposure to the arterial wall. For instance, Medtronic Plc, a medical equipment supplier based in Ireland, introduced Onyx Frontier in August 2022. This is a new generation of drug-eluting coronary stent systems that are designed to improve delivery systems founded on the acute performance and clinical data of the earlier generation, Resolute Onyx DES. The new system, Onyx Frontier DES, maintains the same high-quality stent platform as Resolute Onyx and caters to a wide range of patients with diameters between 2.0mm to 5.0mm. The Onyx Frontier DES features significant design improvements such as a revolutionary dual-layer balloon, lessened crossing profile, and enhanced catheter flexibility. These advances lead to a 16% surge in deliverability compared to the former generation of Resolute Onyx DES, while still maintaining radial strength.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/drug-eluting-stent-global-market-report

What Is the Regional Outlook for the Drug Eluting Stent Market?

North America was the largest region in the drug-eluting stent market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the drug eluting stent market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15557

This Report Delivers Insight On:

1. How big is the drug eluting stent market, and how is it changing globally?

2. Who are the major companies in the drug eluting stent market, and how are they performing?

3. What are the key opportunities and risks in the drug eluting stent market right now?

4. Which products or customer segments are growing the most in the drug eluting stent market?

5. What factors are helping or slowing down the growth of the drug eluting stent market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model